genetically alter the mouse genome with nucleotide Molecular techniques now allow the design of precise ge-precision. Not only does this allow the direct assessnetic modifications in the mouse. Not only can defined nucle-ment of gene function in intact animals, it also otide changes be engineered into the genome of the mouse, allows the design of increasingly useful animal modbut genetic switches can be designed to target expression els of human disease.
or ablation of any gene (for which basic molecular information
Incorporation of exogenous DNA into the mouse is available) to any tissue at any defined time. These strate-genome to produce a transgenic animal can be gies promise to contribute substantially to an increased un-achieved by pronuclear injection of DNA in the fertilderstanding of individual gene function in development and ized zygote. Transgenic animals produced by this pathogenesis. A powerful tool, both for the design of such method are generally gain-of-function mutants since genetic switches and for speeding the creation of gene-modi-the transgene is designed either to express a novel fied animals, is the Cre site-specific DNA recombinase of gene product or to misexpress a normal gene. Precise bacteriophage P1. Precise DNA rearrangements and genetic alteration of endogenous genes (gene targeting) is switches can be efficiently generated in a straightforward accomplished by homologous recombination in emmanner using Cre recombinase. In conjunction with inducible bryonic stem (ES) cells and has been used extensystems for controlling Cre expression and function, these sively to generate null or ''knockout'' mutations. The recombination-based strategies are likely to have a profound derivation from preimplantation embryos of murine impact on developmental biology and the generation of useful ES cells that retain totipotency even after gene taranimal models of human disease. ᭧ 1998 Academic Press geting has allowed the generation of intact animals harboring the desired genetic alteration. Gene-targeted ES cells are injected into blastocysts and upon colonization of the germ line allow generation of intact animals with the desired genetic alteration. Detailed descriptions of these procedures are readily For nearly a century the mouse has been used available (1, 2) . for genetic analysis, with this work leading to key More recently, strategies exploiting site-specific insights in immunology, cancer biology, and develop-DNA recombination have been incorporated into ment. Over the past 20 years the adoption of molecutransgenic and gene-targeting procedures to allow lar biological techniques for the genetic manipulain vivo manipulation of DNA in ES cells or living tion of the mouse has resulted in a vast surge of animals. A large number of site-specific DNA recominterest in using the mouse as a model system for binases have been described from bacteria and yeast, the investigation of almost all facets of mammalian biology. Remarkably, it has now become possible to and the recombination reactions that they catalyze span a wide range of complexity (3) . Most catalyze determination of the suitability of Cre for genomic manipulation in eukaryotic cells (12) . efficient DNA recombination at sequences of from Not all 34 bp are essential for efficient recombina-25 to 150 bp in length, a size sufficiently large that tion: the first 4 bp (from left to right in Fig. 1 for these recognition sequences are not expected to natthe left-hand repeat) of either of the 13-bp inverted urally occur in the mammalian genome. The relative repeats can tolerate some modification with little if simplicity and efficiency of Cre recombinase from any loss of recombinational proficiency or fidelity temperate phage P1 has made it particularly useful (13, 14) . Modified lox sites are helpful in the design for this purpose. Placement of recombination sites of genetic switches (see below). into the genome and subsequent targeted expression
Because each of the 13-bp inverted repeats of the of recombinase have allowed the development of geloxP site binds a single Cre monomer and because netic switches that can either ablate or turn on any
Cre acts virtually stoichiometrically, the number of desired gene in transgenic or gene-modified mice.
functional Cre molecules required for DNA synapsis and recombination is most likely 4 per recombination event (15) . This is approximately what has been observed both in vitro and in Escherichia coli (un-
Cre-MEDIATED RECOMBINATION
published results), although higher concentrations of Cre may be required in the environment of the eukaryotic cell (16). Consideration that the prokaryCre is the 38-kDa product of the cre (cyclization otic Cre protein might not enter the eukaryotic nurecombination) gene of bacteriophage P1 (4, 5) and cleus efficiently prompted the construction of Cre is a site-specific DNA recombinase of the Int family fusions carrying the nuclear localization signal (6) . Because Cre is of prokaryotic origin, gene and (NLS) of SV40 T-antigen (17). Since Cre itself carries protein designations follow standard bacterial gea signal(s) that directs localization exclusively to the netic nomenclature (7) . This convention also helps to cell nucleus in cultured mammalian cells (18), it is avoid potential confusion with the similarly named unclear to what degree addition of an exogenous CRE (cAMP response element). Cre plays two criti-NLS might contribute to enhanced site-specific recal roles in the life of P1: it provides a backup mechacombination. nism for cyclizing P1 DNA after infection (8, 9) , and it enhances P1 plasmid stability in bacterial lysogens by resolving dimeric plasmids for increased partition fidelity at bacterial division (10).
Cre recognizes a 34-bp site on the P1 genome called loxP (locus of X-over of P1) and efficiently catalyzes reciprocal conservative DNA recombination between pairs of loxP sites (11) . The loxP site consists of two 13-bp inverted repeats flanking an 8-bp nonpalindromic core region that gives the loxP site an overall directionality that, by convention, is as depicted in Fig. 1 . Cre-mediated recombination between two directly repeated loxP sites results in excision of the DNA between them as a covalently closed circle. Cremediated recombination between pairs of loxP sites in inverted orientation will result in inversion of the intervening DNA rather than excision. Breaking and joining of DNA is confined to discrete positions within FIG. 1. Cre-mediated excisive recombination. Shown is the lox 2 the core region and proceeds one strand at a time neo plasmid pBS479 in which the PGKneo gene from pPNT (66) was placed between the two directly repeated loxP sites (indicated by way of a transient phosphotyrosine DNA-protein by open arrows) of pBS246 (20 teristics are key features that prompted the initial Lakso et al. (19) showed that the SV40 tumor anti-
TURNING GENES ON
gen gene could be rendered completely quiescent by interposing a synthetic STOP sequence (consisting There often arise instances where introduction of of the SV40 early polyadenylation signal, a false a transgene into the mouse results in either morbid-translational start, and a splice donor signal) beity or such reduced viability that it is difficult or tween it and a lens-specific promoter. Resulting impossible to maintain the transgenic mouse line by transgenic lines exhibited no incidence of tumor forbreeding. In such circumstances it is advantageous mation. On mating with a Cre mouse to generate to design a dormant transgene that can be activated doubly transgenic mice, recombinational activation after establishment of the transgenic line. One way of the tumor antigen gene occurred and resulted in of doing this is by inserting a lox 2 STOP cassette (19, the development of lens tumors in the offspring. 20) between the (potentially toxic) transgene and its A critical issue in using the lox 2 STOP strategy is promoter (Fig. 2) . After establishment of a trans-that after recombination the remaining loxP site genic line, the STOP signal can be removed by Cre-must not interfere with expression of the target mediated excision, for example, by intercrossing transgene. Note that loxP contains two ATG translawith a second mouse expressing Cre, to activate the tional start signals in one orientation (underlined in Fig. 1 ), but not in the other. Hence, it is important transgene as desired. that the lox 2 STOP cassette be oriented as shown in icism in expression of both the cre transgene and the lox 2 STOP-tagged transgene could seriously hamper Fig. 2 so that there remains no false ATG start that could interfere with downstream transgene expres-the attempt to activate gene expression in a majority of cells in the target tissue. For example, random sion after excisive recombination. A second concern is that because of its palindromic structure, the loxP mosaic expression in 60% of the target cell population for both the cre and the reporter transgenes sequence will form a hairpin structure in transcribed RNA that can, if present in the 5 leader, decrease would limit final reporter expression to only 36%.
Acceptibility of such limitations will depend on the downstream gene expression (21, 22) . As discussed above, to minimize translational effects of lox that dictates of the particular experiment being planned.
In the case of generating conditional knockout mutacould affect gene expression in the design of a genetic switch, the loxP hairpin can be destabilized by intro-tions (see below), mosaic cre expression may be a serious problem. Thus it would be prudent to screen ducing a recombinationally neutral alteration of one or more of the outer 4 bp into one of the site's in-transgenic lines for high penetrance of expression or, alternatively, to ''knock-in'' (26) the cre or reverted repeats (23) .
The tissue specificity of expression for the recom-porter genes by homologous recombination in ES cells to a specific chromosomal locus displaying the binationally activated dormant transgene is a function both of the promoter specificity of the target desired expression pattern. transgene and of the promoter specificity of the Cre transgene. For example, use of a Cre transgenic mouse that expresses the recombinase ubiquitously, CONDITIONAL KNOCKOUTS AND MARKER or that expresses Cre in the zygote, will allow activa-EVICTION tion of the dormant transgene so that the resulting expression pattern will be dictated solely by the promoter of the activated transgene. On the other hand, Homologous recombination in pluripotent ES cells allows the targeted generation of a null or knockout mating with a Cre mouse that expresses recombinase in a spatially or developmentally limited fash-mutation in mice. After gene targeting in ES cells, the desired mice are generated by blastocyst injecion will confine activation of the dormant transgene to the intersection of the two expression patterns.
tion of the altered ES cells, subsequent germ line transmission of the engineered mutation, and approCre expression and ensuing recombination will evict the STOP sequence to allow target gene expres-priate matings to render the mutation homozygous.
Because a null mutation can result in embryonic sion not only in the cell in which recombination takes place but also in its progeny. Thus the lox 2 STOP lethality that is noninformative for a gene's role either later in development or in the adult, it would be strategy is a generally useful strategy both for characterizing the expression pattern of a cre transgene useful to devise conditional mutations of the target gene. Moreover, conditional mutations that could be and for conducting lineage analysis in the mouse. A step in this direction is the development of a chicken confined to a particular cell lineage would greatly aid in the determination of a gene's function in that b-actin promoter/lox 2 STOP/lacZ reporter mouse that gives b-galactosidase expression in the nervous cell lineage or tissue.
Both dominant negative mutants and antisense system after Cre-mediated transgene activation (24) . Mating with a a-CaMKII-cre mouse activated RNA have been used to block activity of a target gene and thus can, in principle, be used to generate expression of b-galactosidase in the CA1 cells of the cortex and hippocampus 3 weeks after birth in the a null phenotype. In those situations where such strategies are likely to be effective, conditional exdoubly transgenic offspring. Note that cells that have become blue show either that Cre is being ex-pression of the dominant negative mutant can be attained by using the lox 2 STOP strategy discussed pressed in those cells or that Cre had been expressed in the lineage leading to it. above. After activation by mating with a cre transgenic with the desired tissue specificity, the A complicating factor in these strategies is position effect variegation of the transgene (25) . Position dominant negative will be expressed in a manner dependent both on the pattern of Cre-mediated actieffects can lead to mosaicism of transgene expression in the target tissue and also to unexpected expres-vation and on the promoter specificity of the activated transgene. Although this strategy may be usesion in other tissues, depending on the site of integration of the transgene. Clearly, concomitant mosa-ful for those genes for which there already exists sufficient information to allow the design of a domi-cific gene may be expressed in a particular adult tissue, for instance, in which there is also expressed nant negative mutant or a potent antisense construct, it is unlikely to be easily applicable to all a related gene that appears to perform a similar role. Construction of the appropriate double-genegenes.
An attractive alternative strategy for generating modified animals carrying conditional knockout mutations in these genes should allow a more accurate a spatially or temporally controlled conditional mutation is to modify the target gene by homologous assessment of the relative contributions of the two genes to normal cell function in these tissues. In recombination in ES cells so that it is flanked by loxP sites (Fig. 3) . Mice containing such a modified addition to Cre-mediated conditional loss-of-function mutations, conditional gain-of-function mutations gene are then crossed with mice expressing Cre in the desired target tissue, and Cre-mediated excision can be designed to elucidate gene function. For example, an endogenous gene of interest can be disresults in tissue-specific gene ablation. This strategy was first demonstrated by Gu et al. (27) using a rupted or knocked out with the lox 2 STOP cassette and then reactivated in a tissue-specific or tempomouse in which the promoter and first exon of the DNA polymerase b gene (polb) were flanked by loxP rally specific manner by mating with an appropriate Cre-expressing mouse. sites. When mated to a transgenic mouse that specifically expressed Cre in T-cells, the polb gene was
Crucial to the success of these procedures, however, is the prior careful evaluation of the pattern inactivated in 40% of the T-cell population, but not in any other tissue. Incomplete elimination of the of expression of the cre transgenic animal. Clearly, mosaic expression of recombinase in the desired tispolb gene from the targeted cell population in this instance may have been due to use of a wild-type cre sue (or at the desired time) would defeat the intent to effect complete gene ablation in the target cell transgene and most likely could be remedied by using a cre gene carrying a ''Kozak'' modification (17, population. Conversely, unexpected expression of Cre in extraneous tissues would lead to gene abla-28, 29) that allows efficient translation in mammalian cells. Recombinational eradication of an endoge-tion outside of the tissue of interest and thus complicate interpretation of the experiment. Mosaic gene nous gene can thus be targeted to a particular tissue or time by simply controlling expression of cre. Such expression is not uncommon in transgenic animals and is likely to be a function both of the site of integaconditional knockouts will be invaluable in obtaining a more complete understanding of gene function for tion and of the susceptibility to position effects of the promoter element. Judicious choice of a promoter genes that both play an essential role in the embryo (hence null mutations would be embryonic lethal) displaying both position-independent gene expression and the correct combination of spatial and temand provide a vital function in a particular adult tissue.
poral specificity would, of course, be ideal, and some promoter/gene cassettes appear to manifest these A particularly powerful feature of a conditional gene inactivation strategy using Cre is that the same properties. Alternatively, the use of chromatin insulator elements (30) may help in achieving these goals loxP-tagged mouse can be used for gene ablation independently in a large number of different tissues, by ameliorating the effects of adjacent chromosomal sequences on expression of the cre transgene. In or at different developmental times, by simply mating it with a corresponding cre transgenic that dis-some cases, though, it may be preferable to obtain the desired specificity of expression by knocking-in plays the desired tissue or temporal specificity of expression. Thus, the same genetically modified ani-the cre gene at a chromosomal locus displaying the desired pattern of expression. mal can be used to answer a variety of different questions relating to the expression and function of the The existence of both polyclonal (12) and monoclonal (31) antibodies to Cre permits Western and target gene. The use of the loxP-tagged conditional mutation strategy is doubly appealing because of the immunohistochemical analyses of candidate cre founder transgenic lines. Immunological techniques potential savings in effort and time that is necessarily associated with gene modification in ES cells and can thus be used to rapidly obtain a rough idea of the tissue-specificity of expression and to detect possible subsequent generation of an animal carrying the engineered mutation. mosaicism in expression. Functional analysis of Cre activity, however, is the acid test for suitability of a Conditional loxP-tagged mutations will also be of great value in distinguishing the relative roles of particular transgenic or knock-in cre mouse for use in a particular conditional knockout or gene activagenes with apparently overlapping functions. A spe- designed   FIG. 3 . Conditional gene ablation by Cre recombinase. The target endogenous gene is modified by homologous targeting in ES cells so that it is flanked by two directly repeated loxP sites (for simplicity, only one allele is shown). In those situations that require removal of the neo gene, a third loxP site is positioned so that neo can be excised by transient expression of cre in ES cells. The HSVtk gene can be incorporated into the neo interval to permit direct selection for Dneo (27) . After identification of Dneo clones that retain the loxP-flanked target gene, mice are generated from ES cells by standard procedures. Mating of the loxP-modified mouse with a cre transgenic will generate a double-transgenic mouse in which the loxP-modified gene has been deleted in those tissues in which the cre transgene has been expressed. In the example shown, cre is expressed in the ears (striped) of the cre transgenic so that deletion of the loxP-modified target gene is confined solely to the ears (white) of the double transgenic.
primers. Still, the most satisfying analysis would colonies resistant to gancyclovir (TK 0 ) are screened for the desired deletion. The ratio of complete exciallow a simple determination of the recombinational competence of each individual cell in the target tis-sion (target gene / neo) to deletion only of the neo interval is probably a function of the amount Cre sue. As mentioned above, a reporter mouse carrying a lox 2 STOP/lacZ transgene, that when activated activity introduced into the cell and thus is dependent both on the promoter used for cre expression gave good expression of lacZ in the nervous system, served as a powerful tool for identifying a cre and on the amount of DNA electroporated into cells.
In addition, the frequency of loxP 1 loxP recombinatransgenic with the desired pattern of expression in CA1 cells (24) . This cre animal was then chosen to tion may be sensitive to the distance between the sites (see below), allowing preferential excision of effect the specific ablation of a loxP-modified NMDA receptor gene in CA1 cells and thereby demonstrate the neo interval in most cases.
Efficient eviction of the selectable marker by Cre a function for this receptor in spatial memory in the mouse (32) . Reporter mice capable of expressing lacZ can also simplify other genome modification procedures in ES cells. Introduction of point mutations in all cells after Cre-mediated activation would be of great benefit in speeding the careful evaluation into a gene of interest can be achieved by the strategy shown in Fig. 4 , using a lox 2 neo cassette (such of the specificity of cre transgene expression, and a number of laboratories are currently developing as that shown in Fig. 1 ) for the selectable marker.
After identification of those G418 R transformants in such mice (33) .
In knockout strategies, the endogenous locus in which homologous recombination has replaced one copy of the endogenous gene with the mutant variant the mouse genome is targeted for loxP modification by homologous recombination in ES cells using a on the targeting construct, the neo gene can be removed by Cre-mediated recombination, leaving beselectable marker, usually neo. Homologous targeting is achieved by standard procedures, with the hind only the 34-bp loxP site. Unless placed in a coding exon or another critical region of the gene, targeting construct having a region of DNA homology that is 5 to the target locus and another DNA the loxP site is unlikely by itself to interfere with gene expression. Marker eviction by Cre also means segment that is homologous to the 3 region. Sandwiched in between for conditional knockout strate-that the selectable marker can be ''recycled'' for use in a second round of gene targeting (12, 38) . This gies are the loxP-flanked region of the target gene destined for Cre-mediated excision and also the neo strategy has been used to sequentially disrupt both alleles of a target gene in ES cells with the same selectable marker. Optionally, the thymidine kinase gene (tk) of herpes simplex virus (HSV) can be ap-selectable marker (39) . Marker recycling is useful because there are only a few different selectable pended to one of the homology arms to enhance the recovery of homologously targeted integrants using markers that have been shown to work well in ES cells and also to allow use of a single line of drugpositive-negative selection (34) .
Because the neo gene can itself adversely affect resistant feeder cells, since the feeder cells on which the ES cells are grown should also be resistant to gene expression of neighboring genes (35) (36) (37) , it may be important, depending on the positioning of the drug used for selection.
Cre catalyzes excisive recombination at chromothe neo gene in the final targeted chromosomal locus, to be able to remove the neo gene from the targeted somal lox sites in 80-100% of cells into which a transient cre expression vector is introduced (18, 20) . locus in a second step. Figure 3 shows that one way of achieving neo removal is to include a third directly Hence, the major impediment to efficient lox 2 marker eviction is the efficiency of DNA transfecrepeated loxP site in the original targeting construct. Thus, one loxP-flanked interval is the gene designed tion, which can be fairly low (°5%) in ES cells using electroporation. As mentioned above, one solution for conditional inactivation, and the other loxPflanked interval is neo itself. Complete Cre-mediated is to simply select for excision with gancyclovir by including HSVtk on the DNA segment to be excised. excision would, of course, remove both the neo gene and the targeted loxP-flanked DNA segment. How-A slight drawback to this strategy is that integration of the tk marker into the genome precludes its use for ever, transient expression of Cre in ES cells can lead to partial DNA excision, removing only the neo inter-positive-negative selection in the original targeting construct. A promising alternative strategy, which val (27) . To allow selection for the neo deletion, the HSVtk gene is included in the neo interval. After does not impose an additional round of selective stress on the cells at the marker excision step, is to transient transfection with a Cre expression vector, use an expression vector carrying a gene fusion of rescent cells can be micromanipulated using a microscope equipped for epifluorescence (unpublished green fluorescent protein (GFP) with cre (Fig. 5) . The GFPcre fusion gene readily catalyzes excisive results). Parenthetically it should be noted that since knowledge of the tissue-specific pattern of Cre recombination when transfected into ES cells and also results in bright green cellular fluorescence recombinase expression is critical for conditional gene knockout strategies, the GFPcre gene should (18). By using fluorescence-activated cell sorting (FACS) of GFPcre transiently transfected ES cells, also prove useful for tracing tissue-specific recombinase expression in transgenic mice. an enriched population can easily be obtained in which 80% or more of the cells have excised the lox 2 A nagging worry in all excision strategies in vitro is that multiple rounds of ES cell manipulation may marker or are destined to do so. Sorted cells can then be plated for colony formation and Dneo clones result in a population of cells with reduced totipotence, thus jeopardizing chances that the gene-modiquickly identified for subsequent blastocyst injection. Optionally, recombinationally committed, fluo-fied locus will be transmitted through the germline.
For simple marker removal, the second round of cre expression vector transfection of ES cells can be avoided by using instead a Cre-expressing mouse to remove the selectable marker. ES cells carrying the desired gene modification with a lox 2 neo gene are injected directly into blastocysts to generate a chimera, as would be done in a standard knockout strategy. The chimera is then mated with a Cre-expressing mouse to excise the neo gene. Both CMV-cre (19, 40) and EIIa-cre (41) mice have been found useful for giving germline excision of neo. Alternatively, the neo gene can be excised by directly injecting zygotes 
In the case of the EIIa-cre mouse, the EIIa pro-sumes a selectable marker, and neo, hph (hygomycin resistance), and pac (puromycin resistance) have moter is active early in development, with high-level expression in the one-cell zygote and cessation of been used successfully in ES cells for this purpose.
To facilitate subsequent selection for the desired reexpression after implantation (44) . The extent of excisive recombination is thereby frozen early in devel-combination product, Hprt 0 ES cells are used for the two rounds of homologous targeting, and compleopment and, by extension, also in the germline. Transgenic animals can thus be generated having mentary halves of a loxP-Hprt fusion gene are placed at each rearrangement endpoint. Doubly tardifferent numbers of copies, and correspondingly different levels of expression, of a particular transgene geted ES cells are then transiently transfected with a cre expression vector to catalyze recombination. at the same integration site. This strategy was used to demonstrate that oncogenicity in the embryonic This strategy has been used to directly select both a t(12;15) translocation between the IgH and the clens from SV40 T-Ag expression could be significantly delayed by reducing the copy number of the myc loci (46) and deletions and inversions at the HoxB-wnt3 interval on chromosome 11 (48) . T-Ag transgene to 1 (41) .
The Cre-mediated t(12;15) translocation was obtained at a frequency of about 5 1 10
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. Inversions and deletions of 90 kb or 1 Mb at the HoxB-wnt3
INTERMOLECULAR RECOMBINATION AND
interval arose either at a similar frequency of about CHROMOSOME TRANSLOCATIONS 1 1 10 07 or at a frequency of 1-5 1 10 05 , depending on the particular double-targeted ES clone. Clones giving the higher recombination frequency are those Cre catalyzes not only intramolecular DNA recombination (excision and inversion) but also in-in which loxP sites have been targeted to the same chromosome homolog. Interestingly, the frequency termolecular recombination (integration and translocation). In cultured mammalian cells, this has been of recombination in clones having loxP sites on different homologs was substantially lower and apexploited to direct site-specific insertion of an introduced loxP-containing plasmid to a loxP target in the proached the frequency seen with translocation between chromosome heterologs. Cre also catalyzed chromosome by cotransforming with a transient expression cre vector (29) . Stable insertions are obtained DNA recombination between loxP sites located relatively far from each other in the HoxB-wnt3 interval from trapping the inserted DNA in the chromosome after a short burst of Cre activity. Although site-spe-to generate inversions and deletions of 3-4 cM, albeit at a frequency somewhat lower than that seen cific integration occurs more frequently than homologous targeting, identification of targeted integration for the shorter distances of 90-1000 kb.
For Cre-mediated inversions and deletions, design events still requires the use of a selectable marker. Because the loxP target must first be placed into the of the targeting Hprt-loxP constructs to permit Hprt / selection is straightforward if the relative origenome (for example, by homologous recombination or by a more random method) it is convenient to incorpo-entation of the target loci is known. Correct orientation of the loxP sites is important to avoid the prorate the loxP site as part of a fusion gene, half of which is placed at the chromosomal target and the other half duction of dicentric and acentric chromosomes after recombination. Such aberrant chromosomes would of which is on the targeting plasmid vector. Upon Cremediated recombination, a selectable marker gene is likely result in either cell inviability or loss of a normal karyotype and failure to contribute to the germreconstructed, thereby permitting direct selection for the targeted chromosome insertion. A variety of loxP line. Often, however, the relative orientation of the target loci either to each other or to the centromere fusion markers have been generated for this purpose, including tk (29) , neo (23) , hisD (45) , and, in ES cells, is unknown. In these circumstances, it may be necessary to target each locus with both possible HprtHprt (46) .
In a similar fashion, Cre can be used to orchestrate loxP orientations (48) to ensure that a suitable double-targeted configuration is obtained. the production of precise chromosome translocations, deletions, and inversions (46) (47) (48) (49) . This is ac-A slightly different strategy that did not require the use of Hprt 0 ES cells was used to generate a complished by first positioning loxP sites by homologous recombination in ES cells at the desired 200-kb deletion of the amyloid precursor protein (APP) locus (49) . Two rounds of homologous recombi-tion at loxP sites placed into the genome (51), for the most part, recombination appears to be primarily nation were used to target loxP sites to the desired deletion endpoints and also to position the HSVtk dependent only on the availability in the cell of Cre recombinase for recombination. Hence, in principle, gene between the two directly oriented loxP sites. After transient transfection of the doubly-targeted the spatial and temporal occurrence of recombination can be completely specified by placing cre under ES cells with a cre expression vector, selection for resistance to FIAU resulted directly in the desired the control of a promoter having the desired spatial and temporal pattern of expression. In actuality, APP deletion. An intriguing alternative procedure that combined the second homologous targeting step however, some tissue-specific promoters may also be expressed at low levels in unwanted tissues or at with the Cre-mediated excision step was also presented. After placement of a loxP site at the first inopportune times during development. Moreover, transgene position effects can also contribute to undeletion endpoint along with the correctly positioned HSVtk gene, cells were cotransfected with the second expected expression. Because even low levels of Cre expression may lead to recombination in some fracloxP targeting vector and also with a cre expression vector. Simultaneous selection for FIAU resistance tion of a cell population, use of a tightly regulated and well-characterized promoter is important in diand for the dominant selectable marker on the second targeting construct (hph) directly gave the de-recting recombination to the correct target tissue at the correct time without unwanted recombination in sired APP deletion. Although the frequency of recovery for the desired deletion was low, the substantial nontarget tissues.
An attractive alternative to native promoters is to savings in time and effort achieved by this method is extremely attractive.
use synthetic inducible systems to control cre expression. The elegant tetracycline-regulated transcripThe ability to design precise inversions, deletions, and chromosome translocations in the mouse genome tional systems (52, 53), presented in detail elsewhere in this issue, offer the possibility of inducing cre exwill have a profound impact on genetic mapping and strain construction in mice (20) . In particular, many pression at a desired time either by simply dosing an animal with tetracycline or by withdrawing animals of the procedures worked out in Drosophila with novel chromosomes should be applicable to the mouse. Be-from tetracycline administration. In this strategy the cre gene is placed under the control of a minimal cause Cre-mediated recombination is reciprocal, recombination between similarly oriented (with respect promoter (that by itself is transcriptionally silent) carrying a reiterated tet operator sequence. Tranto the centromere) loxP sites placed at distinct loci on different chromosome homologs will result in both a scriptional activation is achieved in cells that express a tet repressor-VP16 transcriptional activator deletion on one chromosome homolog and a duplication of the target interval on the other. Such balanced fusion gene (tTA). Addition of tetracycline (or a tetracycline analog) prevents binding of tTA at the opCre-mediated recombination events have indeed been obtained in ES cells (48) . The generation of defined erator sequences to terminate gene expression. A variation is to use a mutant tet repressor-VP16 fusegmental aneuploidies in mice will be useful not only in facilitating saturation mutagenesis of a predesig-sion that binds to operator DNA and thus activates gene expression only in the presence of tetracycline. nated chromosome interval, but also in evaluating the effect of increased or reduced ploidy of defined chromo-Although mosaicism of transgene expression has some regions. This approach may be particularly valu-limited the success of initial attempts at tetracycline able in identifying important chromosome regions that control of Cre-mediated recombination in transgenic contribute to the many different features of trisomy animals (54), it is likely that a judicious choice of 21 by allowing a systematic evaluation of increased promoter elements, or the use of knock-in strategies, copy number of defined chromosome 21 syntenic re-will allow a robust implementation of this methodolgions in the mouse (50; B. Sauer and M. Brennan, ogy. In a similar manner, inducible transcription of unpublished results).
cre by a variety of other drugs or steroids, such as ecdysone (55, 56), RU486 (57) , and dimerization-inducing synthetic ligands (58) , may prove useful in
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mice. An intriguing second type of strategy is to con-
TIME AND SPACE
trol Cre function in the cell by fusing Cre to the ligand-binding domain of a steroid receptor (59-61). Although position effects have in some instances influenced the efficiency of Cre-mediated recombina-In cultured cells, Cre-mediated recombination by the fusion protein is activated upon addition of ligand. will clearly be of considerable assistance in unraveling the complexity of mammalian development and The use both of steroid agonists that do not appreciably target endogenous steroid receptors and of li-in generating more sophisticated models of human disease. gand-binding domains responsive only to exogenously added ligands should allow adoption of this strategy in mice.
A complicating factor in all of these strategies is ACKNOWLEDGMENT that they require multiple time-consuming mouse crosses to obtain within a single mouse the desired constellation of transgenes (for example, the regulat-I am grateful to Dr. U. Hochgeschwender for thoughtful comments on the manuscript. able cre gene, the transactivator gene, and the loxmodified target). For some purposes, an acceptable and much more rapid approach may be possible by viral-mediated gene transfer of Cre recombinase
